Author:
Blair J.M.,Zheng Y.,Dunstan C.R.
Subject
Cell Biology,Biochemistry
Reference21 articles.
1. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function;Anderson;Nature,1997
2. A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women;Bekker;J. Bone Miner. Res.,2004
3. Mechanisms of disease: Roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis;Blair;Nat. Clin. Pract. Oncol.,2006
4. A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer;Body;Clin. Cancer Res.,2006
5. Brown, J. M., Zhang, J., & Keller, E. T. (2004). OPG, RANKL, and RANK in cancer metastasis: Expression and regulation. In Steven T. Rosen (Series Ed.) & E. T. Keller, & L. W. K. Chung (Eds.), Cancer treatment and research series, Vol. 118. The biology of skeletal metastases (Chapter 7, pp. 149–172). Boston: Kluwer Academic Publishers.
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献